Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader‐Willi Syndrome: A randomized, double‐blind, crossover trial,Molecular Genetics & Genomic Medicine

当前位置： X-MOL 学术 › Mol. Genet. Genomic Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader‐Willi Syndrome: A randomized, double‐blind, crossover trial
Molecular Genetics & Genomic Medicine ( IF 1.5 ) Pub Date : 2020-10-25 , DOI: 10.1002/mgg3.1535
Zainab Alyousif ₁ , Jennifer L Miller ₂ , Jeremie Auger ₃ , Mariana Sandoval ₃ , Amanda Piano ₃ , Thomas A Tompkins ₃ , Wendy J Dahl ₁

Affiliation

Probiotics may provide a benefit for adults with Prader‐Willi syndrome (PWS) experiencing constipation. The primary aim was to determine if Bifidobacterium animalis ssp. lactis B94 (B. lactis B94) improves stool frequency, with secondary aims of stool form and gastrointestinal symptoms. Exploratory aims included diet quality and fecal microbiota composition.

中文翻译：

益生菌补充剂对受普拉德·威利综合症影响的成年人的微生物群特征和缓解通便的功效：一项随机，双盲，交叉试验

益生菌可能对患有便秘的普拉德威利综合症（PWS）的成年人有益。主要目的是确定动物双歧杆菌是否属。球菌 B94（乙。球菌 B94）改善排便频率，粪便形式和胃肠道症状的第二个目的。探索性目标包括饮食质量和粪便微生物群组成。

更新日期：2020-12-27

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11